Veradermics (MANE), a developer of an oral hair loss therapy, has filed to sell 13.4M shares of its common stock in its U.S. initial public offering under the ticker symbol “MANE,” seeking a valuation ...

Veradermics (MANE), a developer of an oral hair loss therapy, has priced its upsized IPO at $17.00 per share, offering 15,077,647 shares, with all shares sold by the company. The offering is expected ...

Veradermics Inc., the New Haven drug developer working on an oral treatment for hair loss, said it expects to raise about $181.8 million in its planned initial public offering, funds it says will help ...

Following obesity treatments, hair loss medications have emerged as a new investment target on Wall Street, triggering a surge in domestic "hair loss stocks." Over the past week, JW Pharmaceutical and ...